Alessio David Nahmad is the Director of Research at the Samueli Integrative Cancer Pioneering Institute, Davidoff Cancer Center, Rabin Medical Center. Alessio is a co-founder of Tabby Therapeutics, a seed stage biotech. Alessio has a proven track-record in novel gene and cell therapy characterization and applications as highlighted by multiple awards including the ASGCT Excellence in Research Award and the ESGCT Early Career Investigator Award.